Key facts
- This page summarizes Kim P. Kamdar's Form 4 filing for Evofem Biosciences, Inc. (EVFM).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 Dec 2023, 16:05.
Kim P. Kamdar - 21 Dec 2023 Form 4 Insider Report for Evofem Biosciences, Inc. (EVFM)
- Reporting relationship
- Director
- Issuer ticker
- EVFM
- Reported as of
- 21 Dec 2023
- Net transaction value
- -$6.21
- SEC form
- 4
- Accepted by SEC
- 22 Dec 2023, 16:05:30 UTC
- Prior SEC filing
- 15 Aug 2023
- Next SEC filing
- 31 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Saundra Pelletier
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kim P. Kamdar filed Form 4 for Evofem Biosciences, Inc. (EVFM) on 22 Dec 2023.
Change
- Previous filing in this sequence was filed on 15 Aug 2023.
- Current net transaction value: -$6.21.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EVFM
transaction
Common Stock
Sale
- Transaction value
- $6.21
- Shares
- -10
- Change %
- -100%
- Price
- $0.6210
- Shares after
- 0
- Date
- 21 Dec 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.